CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Rocket Pharmaceuticals Inc - RCKT CFD

12.63
7.02%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-0.24)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.02)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 50.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 11.83
Open 12.33
1-Year Change -56.35%
Day's Range 11.99 - 12.8
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 11.83 0.22 1.89% 11.61 12.04 11.51
Dec 16, 2024 11.70 -0.21 -1.76% 11.91 12.08 11.69
Dec 13, 2024 11.97 -0.43 -3.47% 12.40 12.42 11.71
Dec 12, 2024 12.51 -0.64 -4.87% 13.15 13.32 12.13
Dec 11, 2024 13.33 0.36 2.78% 12.97 14.69 12.93
Dec 10, 2024 13.44 -0.23 -1.68% 13.67 13.79 13.31
Dec 9, 2024 13.77 -0.10 -0.72% 13.87 14.13 13.76
Dec 6, 2024 13.82 0.54 4.07% 13.28 14.10 13.28
Dec 5, 2024 13.26 -0.29 -2.14% 13.55 13.70 13.20
Dec 4, 2024 13.52 0.12 0.90% 13.40 13.94 13.21
Dec 3, 2024 13.44 -0.89 -6.21% 14.33 14.35 13.39
Dec 2, 2024 14.34 0.00 0.00% 14.34 14.52 14.12
Nov 29, 2024 14.34 0.26 1.85% 14.08 14.44 14.04
Nov 27, 2024 14.13 0.04 0.28% 14.09 14.34 13.94
Nov 26, 2024 14.04 0.12 0.86% 13.92 14.10 13.59
Nov 25, 2024 14.04 -0.29 -2.02% 14.33 14.91 13.99
Nov 22, 2024 14.04 1.39 10.99% 12.65 14.12 12.60
Nov 21, 2024 12.74 -0.28 -2.15% 13.02 13.31 12.61
Nov 20, 2024 12.98 -0.01 -0.08% 12.99 13.17 12.56
Nov 19, 2024 13.10 -0.65 -4.73% 13.75 13.75 13.02

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
Leverage
2:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Rocket Pharma Company profile

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc. is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; Leukocyte Adhesion Deficiency-I (LAD-I), is a genetic disorder that causes the immune system to malfunction; Pyruvate Kinase Deficiency (PKD), is a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia, and Infantile Malignant Osteopetrosis (IMO), is a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Rocket Pharmaceuticals Inc revenues was not reported. Net loss increased 21% to $169.1M. Higher net loss reflects research and development expense balanci increase of 15% to $113.5M (expense), General and administrative - Balancing increase of 47% to $24.5M (expense), Stock-based Compensation in SGA increase of 54% to $17.3M (expense).

Industry: Bio Therapeutic Drugs

350 5th Ave Ste 7530
NEW YORK
NEW YORK 10118-7501
US

People also watch

BTC/USD

104,922.50 Price
-1.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

3,884.58 Price
-1.330% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,990.10 Price
0.000% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,637.23 Price
-0.340% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading